Small study tests new way to track hormone therapy effects in breast cancer
NCT ID NCT01553903
First seen Apr 18, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This study looked at whether it is possible to measure certain cholesterol-related substances, called oxysterols, in the blood of women with breast cancer who are taking hormone therapy like tamoxifen or aromatase inhibitors. The goal was to see if these measurements could help understand how the treatment works. The study involved 29 women and lasted about 9 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Claudius REGAUD
Toulouse, 31052, France
Conditions
Explore the condition pages connected to this study.